3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Dermatologic
2
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Sarcoma
16
Osteosarcoma
10
Carcinosarcoma
9
Neoplasm Metastasis
8
Rhabdomyosarcoma
7
Neuroblastoma
7
Melanoma
6
Lymphoma, Non-Hodgkin
6
Endometrial Neoplasms
6
Wilms Tumor
5
Sarcoma, Ewing
5
Rhabdoid Tumor
5
Ovarian Neoplasms
5
Lung Neoplasms
5
Liposarcoma
5
Leiomyosarcoma
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Gliosarcoma
5
Glioblastoma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma, Hepatocellular
5
Sarcoma, Kaposi
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Histiocytoma, Malignant Fibrous
4
Glioma
4
Ependymoma
4
Interventions
Specimen Handling
2
Semaxinib
2
tin etiopurpurin
1
pembrolizumab
1
montanide ISA 51
1
cc-486
1
atezolizumab
1
Tumor Necrosis Factor-alpha
1
Tissue Banks
1
SUB1 protein, human
1
Ritonavir
1
Radiosurgery
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nelfinavir
1
Molecular Diagnostic Techniques
1
Mohs Surgery
1
Melphalan
1
Interleukin-2
1
Interleukin-12
1
Injections
1
Immunotherapy
1
Etoposide
1
Drug Therapy
1
Cyclophosphamide
1
Blood Specimen Collection
1
Biopsy
1
Biological Therapy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Specimen Handling
×
Sarcoma
×
Clear all
NCT07062003
2026-06-04
MBRT1
Mayo Clinic
Phase NA
Recruiting
60 enrolled
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled